Examkin

Soru

Zorluk: ZorPharmacologic Interventions

A 35-year-old woman is brought to the emergency department by her husband due to severe agitation, confusion, and uncontrollable shivering that began abruptly earlier today. She has a history of treatment-resistant major depressive disorder. Ten days ago, her psychiatrist discontinued her fluoxetine regimen due to lack of efficacy. Three days ago, she was started on tranylcypromine. Her temperature is 39.2∘C39.2^\circ \text{C} (102.6∘F102.6^\circ \text{F}), blood pressure is 168/98 mm Hg168/98 \text{ mm Hg}, pulse is 128/min128/\text{min}, and respiratory rate is 22/min22/\text{min}. Physical examination reveals profuse diaphoresis, mydriasis, and hyperactive bowel sounds. Neurologic examination demonstrates severe lower extremity hyperreflexia and spontaneous clonus. Intravenous fluids and lorazepam are administered, but the patient remains highly agitated and her temperature increases to 39.8∘C39.8^\circ \text{C} (103.6∘F103.6^\circ \text{F}). Which of the following is the most appropriate next pharmacologic intervention?

  1. A
    Administer bromocriptine
  2. Administer cyproheptadineCevap
  3. C
    Administer dantrolene
  4. D
    Administer fentanyl
  5. E
    Administer physostigmine

Cevap

The correct answer is to administer cyproheptadine.
The correct intervention is cyproheptadine. This patient is experiencing severe serotonin syndrome, precipitated by the premature initiation of tranylcypromine (a monoamine oxidase inhibitor) only 1010 days after discontinuing fluoxetine. Because fluoxetine and its active metabolite norfluoxetine have exceptionally long half-lives, a minimum 55-week washout period is required before starting an MAOI (compared to 22 weeks for other SSRIs). The diagnosis of serotonin syndrome is confirmed by the triad of altered mental status, autonomic instability (fever, diaphoresis, tachycardia), and neuromuscular hyperactivity (hyperreflexia, spontaneous clonus). When initial stabilization with intravenous fluids and benzodiazepines fails to control severe agitation and hyperthermia, the next step is the administration of cyproheptadine, a potent 5-HT2A receptor antagonist.

Adım Adım Çözüm

1
Analyze the patient's medication history and recent changes.
The patient discontinued fluoxetine 1010 days ago and started tranylcypromine (an MAOI) 33 days ago.
Identifying recent medication changes is crucial for diagnosing toxidromes. Fluoxetine has an exceptionally long half-life and requires a minimum 55-week washout period before initiating an MAOI, unlike the 22-week washout required for other SSRIs.
2
Correlate the medication error with the clinical presentation.
The overlap of fluoxetine and tranylcypromine caused a massive accumulation of synaptic serotonin, leading to autonomic instability (fever, tachycardia), altered mental status, and neuromuscular hyperactivity (hyperreflexia, clonus).
This classic triad definitively diagnoses Serotonin Syndrome and differentiates it from other hyperthermic emergencies like Neuroleptic Malignant Syndrome (which presents with bradyreflexia and lead-pipe rigidity) or Anticholinergic Toxicity (which presents with dry skin and absent bowel sounds).
3
Determine the appropriate escalation of pharmacologic therapy.
Since the patient is failing initial supportive care and benzodiazepines (lorazepam) with worsening hyperthermia and agitation, a specific antidote is required.
Cyproheptadine is a first-generation antihistamine with potent serotonin (5-HT1A and 5-HT2A) antagonist properties, making it the definitive pharmacologic intervention for severe, benzodiazepine-refractory serotonin syndrome.

Anahtar Kavram

Management of Serotonin Syndrome and recognition of fluoxetine's extended washout period before MAOI initiation.
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru